Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Oral Eplerenone for the Management of Acute Serous Chorioretinopathy. Ophthalmology
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Dr. Rebecca Grimes
ISBN: 9786139949717
Год издания: 2019
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 64
Издательство: LAP LAMBERT Academic Publishing
Цена: 17059 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: To determine whether Eplerenone (Inspra,Pfizer), a mineralocorticoid receptor (MR) antagonist, is an effective treatment option for acute central serous chorioretinopathy (CSCR). A prospective analysis was conducted for patients who received off-label oral Eplerenone for the treatment of acute CSCR. Eplerenone was administered orally at a dose of 50mg daily, for a total of 28 days. Patients were observed at baseline and at 3 separate consult visits: 7; 14 and 28 days, with SD-OCT performed at each follow-up.The primary outcome measure of the study, was the best corrected visual acuity (BCVA) following Eplerenone administration. A prospective cohort of 15 eyes in 15 patients with acute CSCR were treated with 50mg/d Eplerenone for 28 days. After 28 days, statistically significant decreases from the baseline were observed in, SRF diameter (P<0.01), SRF height (P=0.001), CST (P<0.01), CV(P<0.01), and CAT (P=0.01). After 28 days, the BCVA was 0.9 +/- 0.1 (P=0.001), compared to baseline BCVA 0.8 +/- 0.1. Complete resolution of subretinal fluid (SRF) was seen in 8 out of 15 (53.3%) eyes. Eplerenone treatment accelerated SRF in acute CSCR, compared to the natural disease course.
Ключевые слова: serous chorioretinopathy, acute chorioretinopathy, chronic chorioretinopathy, Eplerenone